HBOT Conversations:
Dr. Peter Canaday (Part 2)
Dr. Peter Canaday has published work in Applied Physiology, Respiratory Medicine, and Diagnostic Radiology. He has presented at National (USA) and International meetings, and his research supported the eventual FDA approval of a new medical imaging device incorporating digital X-ray tomosynthesis. He has sat on National, State, and Local advisory committees, and given testimony at the State Legislative level in the USA.
Dr. Canaday’s experience with Hyperbaric Oxygen Therapy dates back to the 1980s when he studied HBOT under Dr. Eric Kindwall, “The Father of Hyperbaric Medicine”. Dr. Canaday also co-founded the Hyperbaric Medicine Department at St. Anthony Hospital in Lakewood, Colorado.
From 2007, Dr. Canaday spent time in community radiology practices before settling in New Zealand in 2013 as a Consultant Radiologist. Since 2016, he was employed at a Midlands region DHB and served as Head of Department before retiring in March 2021.
Watch the Podcast
HBOT News Network welcomes Dr. Peter Canaday.
This is Part 2 of Conversations with Dr. Peter Canaday. Part 1 can be viewed here. Dr. Canaday now lives primarily in New Zealand, but his history with medicine and Hyperbaric Oxygen Therapy dates back over 40 years to the United States.
In this HBOT News Network Conversations, Dr. Canaday continues the discussion on COVID-19 vaccines and the suppression of medical data. di Girolamon asks the question, “where do we go from here?”. Dr. Canaday explains that Hyperbaric Oxygen Therapy is one of the most exciting things that has piqued his interest in the medical field. He explains that huge numbers are really starting to be revealed of people who have been negatively affected by COVID, either from the point of long-COVID or from a vaccine injury; and Hyperbaric Oxygen could be potentially very helpful to this population, as it is a natural therapy involving oxygen and pressure that upregulates the anti-inflammatory gene and down regulates the inflammatory gene.
However, Hyperbaric Oxygen Therapy threatens the pharmaceutical companies bottom line and when that happens we all start to see some pretty disturbing things start surfacing — such as the science being buried, fake studies being published showing HBOT to be ineffective, major medical Journals rejecting scientific articles outlining all the adverse affects from the vaccine.
The spirit of humanity needs to be embraced here, and it is not.
Dr. Canaday encourages viewers to learn more at www.nzdsos.com — it’s “New Zealand Doctors Speaking Out with Science“. The NZDSOS is very similar to America’s Frontline Doctors and there is a plethora of educational information that can be learned regarding what happened during the COVID-19 pandemic and is still happening today. Dr. Canaday further encourages us all to open our eyes, hearts and ears as we listen and digest to all of this information. Often times, it’s when doctors keep getting shut down and censored that we all need to be listening closer instead of turning the other cheek.
Dr. Canaday and di Girolamo stresses that everyone should be looking into the God-given miracle of Hyperbaric Oxygen Therapy. Be sure to find a treatment center near you if you are experiencing effects of long-COVID or a vaccine injury.
This HBOT News Conversation was filmed on October 4, 2022
Guest
Dr. Peter Canaday
Following completion of medical school at the University of Massachusetts in 1976, Dr. Peter Canaday took up training as an Internal Medicine specialist at the University of Michigan, followed by sub-specialist training in Respiratory and Intensive Care at the University of North Carolina. He began his medical career in a busy trauma hospital in Denver, Colorado in 1981 and practiced for 12 years. During his time there, he managed many of the types of patients now seen with severe COVID-19, co-founded a sleep disorders laboratory and a hyperbaric medicine department. As well, he participated in a dozen committee assignments, and rose to Chairman of the Department of Internal Medicine. In 1993, Dr Canaday changed career and completed training as a Radiologist at the University of Wisconsin in 1997. During an 8-year period at Creighton University Medical School in Nebraska, he became tenured as an Assistant Professor of Radiology, and head of the section of Pulmonary Radiology. He also served on or chaired over a dozen hospital and medical school committees and was appointed Clinical Coordinator for the Radiology Department during his time there. Dr Canaday has also published work in applied physiology, respiratory medicine, and diagnostic radiology, has presented at national (USA) and international meetings, and his research supported the eventual FDA approval of a new medical imaging device incorporating digital X-ray tomosynthesis. He has sat on national, state, and local level advisory committees and given testimony at the state legislative level in the USA. From 2007, Dr Canaday spent time in community radiology practices before settling in New Zealand in 2013 as a Consultant Radiologist. Since 2016, he was employed at the Taranaki District Health Board and served as Head of Department before retiring in March 2021.
Subscribe Now, It’s Free!
Recent HBOT News
Clinical Trial – Effect of Hyperbaric Oxygen Therapy on Microcirculation
Previous studies shoes that hyperoxia alters microcirculation.The investigators hypothesize
that hyperbaric may restore microcirculation integrity. This hypothesis is supported by a
recent study in rabbits, but no data exists for humans.
The study will expose fifteen healthy volunteers to a succession of different fraction of
inspired oxygen and barometric pressure and assess microcirculatory and macrocirculatory
changes via sidestream dark field videomicroscopy, near-infrared spectroscopy, Laser Doppler,
transthoracic echocardiography and bio-impedancemetry at every step.
Clinical Trial – 3 Local Anesthetics for Spinal Anesthesia in Primary Total Hip Arthroplasty
Spinal anesthesia is commonly utilized for hip replacement surgery. Different medications
used for spinal anesthesia work for different lengths of time. This study will compare three
different spinal anesthesia medications in patients having hip replacement surgery to see if
patients are able to get out of bed and walk earlier after surgery with one medication versus
the others.
Clinical Trial – Comparision of Different Doses of Dexmedetomidine With Low Dose Bupivacaine in Selective Spinal Anesthesia.
The charactereistics of a spinal block varies with the dose of local anaesthetic and the
adjuvant used. Literature review did not show comparison of different doses of
dexmedetomidine with low-dose bupivacaine in saddle block. The rationale of this study is to
determine an optimum dose of dexmedetomidine which in combination with low dose bupivacaine
would provide satisfactory block with hemodynamic stability. This would be beneficial for
patients scheduled for turp, as these pts are mostly elderly with various comorbidities.